chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Moderna  11/12/2021: Patient felt itchy, patient also noticed bumps on feet, arms and breast, also felt bumps in scalp, while washing hair scalp was burning. Started to get bumps on bottom and top of feet. Patient states that it looks like she has developed skin disease from vaccination(s). Has appt for dermatologist on 12/01/2021, was told that she may have eczema.
Expired dose administered to 14 patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered to 14 patients) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 068H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 06-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to 14 patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to 14 patients) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  The vial was initially stored in the refrigerator on 14 Mar 2022.  No treatment information was reported.   This case was linked to MOD-2022-539669 (Patient Link).
Bells Palsy, anti viral & steroid for one week. Mostly gone within a week. Lingering numb feeling in cheek.
Patient received ZOSTAVAX vaccine on 5/26/09 and began having adverse reactions on 5/28/09 of body aches, headache and fever.
Extreme pain throughout entire body.  Fever of 101. A little bit of confusion at times. Chills. Extremely tired.
Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Dizziness / Lightheadness-Medium
feverish, chills, shaking, 99.9 fever, extremely nauseous, Zofran did not work, nausea went away that night, fatigue, red square size of a stamp at injection site, size has increased in size, Dr rx Bactrim antibiotic
Seven days after the first shot in the two shot series I started having difficulty walking without a walker.  Felt like my left leg was not doing what I was asking it to do.  Had neuropathy type pain in my feet and arms; prickly feelings in my finger tips; brain fog; constantly falling until I started using a walker and even falls while using a walker; very unstable when standing; tremors; incontinence; fatigue; joints are stiff; can't use my wrists; I get worn out taking a bath and shaving; there is no way I can work; and insomnia,
This spontaneous report was received from a pharmacist referring to a female patient of unknown age. Information regarding the patient's concurrent conditions and medical history was not provided. On 25-MAY-2016, the patient was vaccinated with an expired dose of ZOSTAVAX, 0.65 ml, subcutaneously (lot # K026365, with an expiration date of 15-MAR-2016). Information regarding the patient's concomitant medications was not reported. No adverse effects were reported. Additional information has been requested.
I had my vaccination on 09/16/2022. I started to feel fatigue and nasal congestion on 02/02/2023. I went to the emergency room on 02/04/2023 and tested COVID-19 Positive. The symptoms lasted for 4 days with no course of treatment.
leg pain starting after vaccination. 5/26/23-6/6/23.  Fever of 103 today 6/6/23
While pt was in waiting area for monitoring time, he asked PCT for a drink of water, she noticed that he looked pale, so she alerted the NP.  NP went out to waiting area with cool paper towels, found pt with head on left shoulder and eyes closed.  NP tapped pt on shoulder and asked if he was ok, pt became alert immediately.  Pt's face was pale and shirt was very sweaty.  He said that this had happened a couple of times before when he has received immunizations.  Placed wet paper towels on pt's forehead and neck.  He drank some water.  He said that he was feeling better as soon as he came to.  Color was coming back into his face.  NP monitored pt directly for 15 minutes more after this. BP at this point was 100/64, pulse 72.  Color was back to pt's face, had him stand up for 2 minutes before allowing him to leave the clinic area.
A legal complaint was received from an attorney alleging that a male child received series of HibTITER, DTP, Engerix-B, and Fluzone vaccines as well as a dose of Tripedia vaccine from Dec 5, 1996 through Dec. 9, 1996 and subsequently "suffered devastatin injuries through mercury toxicity and associated complications and sequelae and the aggravation of other conditions directly through exposure, via intramuscular injection of mercury" in the "thimerosal-containing vaccinations." According to the legal complaint, the child "was born a perfectly normal, healthy boy whose APGAR scores at birth were well within the normal range." It is alleged that at approximately 12 months of age, the child "was neurologically devastated by the accumulation of mercury in his body, having been exposed via intramuscular vaccinations, and suddenly regressed developmentally, losing milestones of neurological development previously achieved, specifically including, but not limited to becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior and the loss of language skills, motor skills and affect." According to the legal complaint, the child "suffered severe and permanent injuries" and "sustained and will sustain in the future a mental, intellectual, developmental and neurological incapacity and associated learning disabilities, affect disorders and impairments." Vaccination information contained in the legal complaint indicated that the child received Tripedia and Fluzone vaccines beyond 12 months of age.
Approximately 5 mins after vaccine administration pt began developing hives on the left side of her face.  Administered 10mL of Benadryl. 20 mins post administration no improvement. Pt was directed to PCP for immediate office visit. Pt reported developing the similar reaction after the first dose (delayed response, hives developed ~5 hours later, seen at urgent care center)
Chest pain; elevated Troponin; suspect Myocarditis; possibly after Moderna vaccine.
Large red, no itchy site on right outer thigh over. Pt noted over around 11am. Child was not complaining. Treated with Augmentin 250/5 tip bid, Atarax x 5. Redness at inj. site, indurated, warm.
Severe global aches and pains  Mild fever Moderate to severe headaches Mild stomach discomfort
Initial report was received 20 July 2009 from a health care professional. The following case information pertains to one patient out of a cluster of two vaccines; the other patient has been captured in case 2009-03125. A 48-year-old female patient with a history of hyperlipidemia had received an intramuscular left deltoid injection of ADACEL, lot number C3250AA on 17 July 2009 and an unspecified amount of time later, she complained of an egg size bump that was warm to touch, and pain in her entire upper arm. The needle size utilized for vaccine administration had been 5/8 inch in length. The patient had not been evaluated by her physician; however her physician prescribed AUGMENTIN for the patient prn. The patient had been taking "VITORIN" and ZYRTEC prn concomitantly at the time of vaccination and she had no known allergies. She had not received any other vaccines concomitantly or within four weeks prior to receipt of ADACEL. At the time of the report, the patient had not recovered. Follow-up information received on 26 August 2009 from a health care professional. The patient was 49 years-old at the time of the adverse events. The ADACEL had been administered at 09:30 hours on 17 July 2009. The patient had received 875 mg of oral AUGMENTIN twice a day for seven days. The patient recovered; however the date of recovery was not reported. No further information is expected. The reporter for this case is the same as for case numbers 2009-03123 and 2009-03125. Documents held by sender: None.
(L) upper arm erythema 24cm long and 14cm wide, Temp 98.3; Induration 8.5 cm long x 8 cm wide; tender to touch. Checked by Dr. Advised cool compresses, elevation.
Fatigue, Fever, Body Aches, Headache, Fatigue, Pain and swelling injection site
10 min after vaccination became diaphoretic, decreased level of consciousness, decreased BP  EMS called to site, client stabilized and refused transport to hospital.
This spontaneous report was received from a nurse practitioner refers to a 16 week old male patient. On 08-NOV-2013 the patient was vaccinated with ROTATEQ (lot # and expiry date not provided) orally. The nurse practitioner reported that on 08-NOV-2013 the patient was 16 weeks 0 days of age and was administered his first dose of ROTATEQ. No adverse effect reported. There was no product quality complained involved. Additional information has been requested.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 30-AUG-2013, the patient was inoculated with ZOSTAVAX at a physician's office as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. In 2014, the patient was treated at the same physician's office office for a blistering vesicular outbreak which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Patient presented to ED for 2 syncopal episodes and went into cardiac arrest 5 minutes prior to ED arrival in ambulance. She received ACLS measures and alteplase was mixed and administered for pulmonary embolism concern.
Muscle weakness for couple months; This is a spontaneous report from a non-contactable consumer (for self) reported that a patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot number and expiration date were unknown), via an unspecified route of administration on an unspecified date as unknown, single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced muscle weakness for couple months. The consumer asked to provide any resources for assistance or what the process here, like do you have any information on, how to deal with that and helps with any treatment and asked for the medical department. The seriousness criteria of the event was reported as non-serious by the reporter. The clinical outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
The morning after receiving her 4th Pfizer covid-19 vaccine she developed shortness of breath and low grade fever.
Pt. developed hives from neck down & swelling of both hands. Day before this occurred pt. had jt. pain. PCP provided Prednisone.
Developed cellulitis at the injection site; Developed cellulitis at the injection site / red; Developed cellulitis at the injection site / hot to the touch; Developed cellulitis at the injection site / tender to the touch; Injected the vaccine into the fatty tissue of / arm instead of in the muscle; This case was reported by a consumer via call center representative and described the occurrence of injection site cellulitis in a 67-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had shingles infection prior to receiving shingles vaccine).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced injection site cellulitis, injection site erythema, injection site warmth, injection site tenderness and vaccine administered at inappropriate site. The patient was treated with antibiotics nos (Antibiotics Therapy (Unknown)). On an unknown date, the outcome of the injection site cellulitis was recovered/resolved and the outcome of the injection site erythema, injection site warmth, injection site tenderness and vaccine administered at inappropriate site were unknown.   It was unknown if the reporter considered the injection site cellulitis, injection site erythema, injection site warmth and injection site tenderness to be related to Shingles vaccine.  Additional details were provided as follows: The reporter reported by patient herself. The age at vaccination was not reported but could be 64 or 65 years. In 2018 (but she was not 100 percent sure), the patient received Shingles vaccine in the left arm and she thought that the person injected the vaccine into the fatty tissue of her left arm instead of in the muscle, which led to vaccine administered at inappropriate site. After vaccination the patient developed cellulitis at the injection site and the patient described the cellulitis as red, hot to the touch and tender to the touch. The patient stated that she was prescribed an antibiotic and a cream, and the cellulitis resolved in a few days. The reporter consented to follow up.
The patient states that since the morning following her vaccination her left arm has been very hot, swollen, and purple (due to so much swelling). She says that she has had reactions to vaccines or medications in the past, including anaphylaxis, but this is her first dose of this new vaccine. The patient has been using Tylenol and cold compresses for the pain and swelling. A follow up call was made to the patient 7/28/19 (the day after incident reported) but no answer and left voicemail. Patient stated she was going to contact her PCP to find out if the reaction would warrant her to skip final dose of the vaccine.
Patient came in for the first dose of varicella the day after her first dose of the MMR vaccine and reported her arm feeling itchy where the MMR was given with some redness. She was given the first dose of the Varicella the day after the MMR. She was advised to seek medical attention and was seen with clinic. She reported to me that she was taking Benadryl to relieve the itching and is still utilizing the Benadryl to date.
Severe Ear Ringing; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the arm left on 06Apr2021 at 10:30 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin and the patient reported as healthy. The patient did not receive other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the arm right on 16Mar2021 at 10:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 13:30, the patient experienced severe ear ringing. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event severe ear ringing was not recovered at the time of report.  No follow-up attempts are needed. No further information is expected.
Pt admitted to hospital on 7/25/21 with shortness of breath, which turned out to be positive for Covid-19.  Pulmonology was consulted and patient was started on dexamethasone, remdesivir, baricitinib, as well as Tocilizumab.  Started on vapotherm O2 with Fi02 of 100 %.  Despite aggressive measures patient condition deteriorated.  Family made patient a do not resuscitate, and patient expired on 7/28/21.
Tingling of the fingers - both hands. BPs 140/79 (pulse 72), 121/75 (pulse 71). O2 sat 100%.
Beginning around 1830 19 Jan 2021, I began to have pain and achiness in my left arm.  Not at the ejection site, but further down my arm.  With a pain threshold of 1-10 I would give it a 4 When I awoke on 20 Jan 2021 my body was aching, especially the trunk of my body.  I also am having fatigue and a general feeling of being unwell.  My head has a feeling of 'spaciness' and it's hard to concentrate.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 11-FEB-2016, the patient was vaccinated with an expired dose of VAQTA 50 u/1.0 ml injection, 1 ml, intramuscularly, lot # K010195 with expiration date 15-JAN-2016. There were no adverse effects reported. Additional information has been requested.
got the shot and I have had them even more. /18 times,suspected vaccination failure; had them even more/18 times.; This case was reported by a consumer  and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (occurred in 1979).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient was having shingles since 1979. The patient had got the shot and have had them (shingles) even more, in last year 18 times. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation were unknown at the time of reporting.
Narrative: 60yo patient expired at home on 12/29/21 with what coroner suspected was a heart attack. CURRENT PROBLEM LIST: Immunization status (SCT 304250009) Neck pain (SCT 81680005) Low back pain (SCT 279039007) Headache (SCT 25064002) Hip pain (SCT 49218002) Long-term current use of drug therapy (SCT 710814002) Fatigue (SCT 84229001) Erectile dysfunction (SCT 860914002) Fatty liver (SCT 197321007) Dyspepsia (SCT 162031009) Chronic cholecystitis with calculus (SCTGastric polyp (SCT 78809005) Polyp of colon (SCT 68496003) Renal mass (SCT 309088003) Multiple joint pain (SCT 35678005) Liver function tests abnormal (SCT 166603001) Constipation (SCT 14760008) Pityriasis rosea (ICD-9-CM 696.3) Recurrent major depressive disorder (SCTMale erectile disorder (ICD-9-CM 302.72) Diabetes mellitus (SCT 73211009) Essential hypertension (SCT 59621000) Generalized Anxiety Disorder (ICD-9-CM 3Panic Disorder (ICD-9-CM 300.01) Posttraumatic stress disorder (SCT 47505Major Depression, recurrent (ICD-9-CM 296.30) Benign essential hypertension (SCT 12010Chronic low back pain (SCT 55822004) Elevated Liver Function Tests (ICD-9-CM Personal History of Tobacco Use (ICD-9-CM V15.82) Substance Abuse (ICD-9-CM 305.90) Pt had received one covid vaccine (J&J) on 3/17/2021. It does not appear this death is related to the covid vaccine given the length of time btwn death & date of vaccine administration.
Pale, limp, shallow breathing, unresponsive for approximately one to two minutes. Hospitalized one day. CXR, EKG, CBC, U/A. Inconclusive if there was fluid in lung. Treated with Augmentin. Repeat CXR clear (3 days later).
On the 9th: Chills, headache, fatigue, fever 101, no appetite, body aches, horrible joint pain.  On the 10th: what I thought was some acne  On the 11th: more than 5 small bright red fluid filled blisters on face, every couple hours for a week I get about 3 more at a time. They are oozing and painful. Started around mouth and jawline.  - no other new meds, no new face wash, no new detergent. I did try a lotion 1/10 that I had not applied for about 1 month but haven?t used again. Does not match a whole week of new blisters on face. As of 1/16, new blisters still popping up. Only noted on face.  Mild headaches, mild fatigue, mild body aches continue as of 1/16.
Tingling of tongue and lips and tightness in throat within 15 minutes; advised by ED physician not to follow up for 2nd dose.
Information has been received from a pharmacist concerning a patient, who, on 01-JUL-2013 was vaccinated with a dose of ZOSTAVAX, 0.65 ml, intramuscularly (lot # not reported). No adverse effect was reported. Additional information has been requested. Follow-up received from a pharmacist. The patient's demographics were updated. The patient is a 81 year old male patient with diabetes and hypertension. On 01-JUL-2013 the patient was vaccinated with ZOSTAVAX lot # J000853 dose 2, .65 ml, intramuscular. On 01-JUL-2013, number of previous doses 1. The outcome of number of previous doses 1 is unknown. The reporter considered a number of previous doses 1 to be not related to ZOSTAVAX. Additional information has been requested.
Red swollen painful at site of injection. Advised antihistamine, TYLENOL, ice to area.
LUE swelling, pruritus, pain, diffuse erythema, large hard nodule, low grade fever, nausea, vomiting, diffuse body aches, chills, malaise after medical assistant administered DTaP subcutaneously.
Immediately after the shot administration, patient had a "bad taste" in her mouth. She was given water. She was anxious and started to have tunnel vision. Patient had a blank stare, which was probably an absence seizure. This lasted roughly 2-3 minutes. She was able to come out of the seizure and started talking to the pharmacists. She stood up after about 40 minutes, then sat down and had another seizure. Patient came back after about a minute, and was able to stand and leave pharmacy after 30 minutes.